Sun Wei-Lian, Chen Li-Li, Zhang Su-Zhan, Wu Yan-Min, Ren Yue-Zhong, Qin Guang-Ming
Department of Oral Medicine and Periodontology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, China.
Intern Med. 2011;50(15):1569-74. doi: 10.2169/internalmedicine.50.5166. Epub 2011 Aug 1.
To evaluate the effects of periodontal intervention on inflammatory cytokines, adiponectin, insulin resistance (IR), and metabolic control and to investigate the relationship between type 2 diabetes mellitus (T2DM) and moderately poor glycemic control and chronic periodontitis.
A total of 190 moderately poorly controlled (HbA1c between 7.5% and 9.5%) T2DM patients with periodontitis were randomly divided into two groups according to whether they underwent periodontal intervention: T2DM-NT and T2DM-T group. The levels of serum adiponectin, C-reactive protein (CRP), tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), lipid profile, glucose, insulin, homeostasis model of assessment-insulin resistance (HOMA-IR) and homeostasis model assessment of β-cell function (HOMA-β) were measured at baseline and after 3 months.
The levels of clinical periodontal variables, the probing depth, attachment loss, bleeding index, and plaque index were improved significantly in T2DM-T group after 3 months compared to T2DM-NT group (all p<0.01). After 3 months, the serum levels of hsCRP, TNF-α, IL-6, fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c), fasting insulin (FINS) and HOMA-IR index decreased, and adiponectin was significantly increased in T2DM-T group compared to those in the T2DM-NT group (p<0.05 or p<0.01).
Periodontal intervention can improve glycemic control, lipid profile and IR, reduce serum inflammatory cytokine levels and increase serum adiponectin levels in moderately poorly controlled T2DM patients.
评估牙周干预对炎症细胞因子、脂联素、胰岛素抵抗(IR)及代谢控制的影响,并研究2型糖尿病(T2DM)与血糖控制适度不佳及慢性牙周炎之间的关系。
190例牙周炎伴血糖控制适度不佳(糖化血红蛋白[HbA1c]在7.5%至9.5%之间)的T2DM患者,根据是否接受牙周干预随机分为两组:T2DM-NT组和T2DM-T组。在基线及3个月后测量血清脂联素、C反应蛋白(CRP)、肿瘤坏死因子α(TNF-α)、白细胞介素-6(IL-6)、血脂谱、血糖、胰岛素、稳态模型评估胰岛素抵抗(HOMA-IR)及β细胞功能稳态模型评估(HOMA-β)水平。
与T2DM-NT组相比,3个月后T2DM-T组的临床牙周变量水平,包括探诊深度、附着丧失、出血指数及菌斑指数均显著改善(均p<0.01)。3个月后,与T2DM-NT组相比,T2DM-T组的血清超敏CRP、TNF-α、IL-6、空腹血糖(FPG)、糖化血红蛋白(HbA1c)、空腹胰岛素(FINS)及HOMA-IR指数降低,脂联素显著升高(p<0.05或p<0.01)。
牙周干预可改善血糖控制、血脂谱及胰岛素抵抗,降低血清炎症细胞因子水平,并提高血糖控制适度不佳的T2DM患者的血清脂联素水平。